Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Reports on Repligen

Sort by

Repligen: More Detailed Analysis on GE Decision to Manufacture Protein A

Thursday, September 28, 2017 · 9:11 am

Read More

Repligen: Market Likes Spectrum Acquisition and So Do I  (RGEN, Buy, $43.20)

Tuesday, June 27, 2017 · 12:08 pm

Read More

Repligen: A Business Update and Reiteration of Buy (RGEN, Buy, $34.11)

Friday, April 7, 2017 · 4:10 pm

Read More

SmithOnStocks Top Stock Picks for 2017, January 3, 2017

Tuesday, January 3, 2017 · 10:18 am

Read More

Repligen: Very Strong Growth in Sales and Earnings Continues (RGEN, 29.37, Buy)

Wednesday, August 10, 2016 · 2:46 pm

Read More

Repligen: A Detailed Update; Recent Price Drop Makes Me More Positive (RGEN, Buy, $28.50

Wednesday, December 2, 2015 · 8:11 am

Read More

Repligen: Fundamentals Are Exceptional But The Stock Carries A Premium Valuation (RGEN, $39.97, For Paid Subscribers)

Thursday, July 9, 2015 · 8:44 am

Read More

Repligen Makes An Excellent Acquisition (RGEN, Hold/ Buy, $19.04, free content)

Tuesday, June 3, 2014 · 11:29 am

Read More

Repligen Has an Outstanding, Stable Business and Excellent Long Term Growth Potential (RGEN, Hold/ Buy, $14.07, Paid Subscribers Only)

Monday, April 7, 2014 · 3:45 pm

Read More

San Francisco Trip Is the Basis for a Preview of 2014 (Subscribers Only)

Wednesday, January 22, 2014 · 3:48 pm

Read More

Repligen: Looking At 2014 and Beyond- Potential for EPS Growth (RGEN, $12.78) (Subscribers Only)

Tuesday, November 19, 2013 · 11:25 am

Read More

Repligen: A Buy and Hold Stock: OPUS Promises to be a Dynamic New Product (RGEN; $9.87)

Monday, August 19, 2013 · 11:32 am

Read More

Repligen Promises To Be a Cash Flow Machine (RGEN, $6.88)

Tuesday, April 2, 2013 · 3:30 pm

Read More

Repligen: Initiating Coverage with a Buy (RGEN, Buy, $6.13)

Tuesday, December 4, 2012 · 12:35 pm

Read More

There are 14 reports on file.

« Back to Company Reports Index